Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Innovar treatment for Meniere's disease
Autore:
Gates, GA;
Indirizzi:
UnivAWashington, Sch Med, Dept Otolaryngol Head & Neck Surg, Seattle, WA US Univ Washington Seattle WA USA laryngol Head & Neck Surg, Seattle, WA US
Titolo Testata:
ACTA OTO-LARYNGOLOGICA
fascicolo: 2, volume: 119, anno: 1999,
pagine: 189 - 193
SICI:
0001-6489(199903)119:2<189:ITFMD>2.0.ZU;2-Y
Fonte:
ISI
Lingua:
ENG
Soggetto:
ENDOLYMPHATIC SAC SURGERY; VERTIGO; ASTEMIZOLE;
Keywords:
Meniere's disease; Innovar; intractable vertigo;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
22
Recensione:
Indirizzi per estratti:
Indirizzo: Gates, GA UnivWAashington 357923, Virginia Merrill Bloedel Hearing Res Ctr, Seattle, Univ Washington 357923 Seattle WA USA 98101 g Res Ctr, Seattle,
Citazione:
G.A. Gates, "Innovar treatment for Meniere's disease", ACT OTO-LAR, 119(2), 1999, pp. 189-193

Abstract

Patients with intractable vertigo due to clinical Meniere's disease were offered treatment with Innovar, a neurolept analgesic. The patients were from a single clinical practice, had failed conventional dietary and medical treatment and were eligible on clinical grounds for endolymphatic sac surgery. After a follow-up of 2-8 years, 58% of patients had long-lasting relief of vertigo. Hearing was not affected. Risk factors for a favorable responsewere male gender, fluctuating hearing, and early stage of the disorder. Innovar is a safe, cost-effective second-line therapy for patients with Meniere's disease who have failed conventional first-line medical therapy.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/06/18 alle ore 17:02:47